EDGAR Filing Documents for 0001628280-18-014467

Form 8-K - Current report:

SEC Accession No. 0001628280-18-014467

Filing Date

2018-11-16

Accepted

2018-11-16 17:12:25

Documents

Period of Report

2018-11-16

Items

Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K - VIBATIV CLOSING	a8k-vibativclosingnov12.htm	8-K	32237
2	EXHIBIT 2.1 - ASSET PURCHASE AGREEMENT	cpix-redactedtheravanceass.htm	EX-2.1	243327
	Complete submission text file	0001628280-18-014467.txt		276659

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203

Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068

CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 181190604
SIC: 2834 Pharmaceutical Preparations